Q2 FY26 results: consolidated PAT up 2.4x YoY, bonus 1:1 allotted

Profit growth above 25%Exceptional itemResults restatedResults View source PDF Explain this filing

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.5%Reaction day

₹399.00

prior close

₹394.25

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%-2.4% vs market

Pharmaceuticals peers, median of 157sector-0.0%-2.5% vs sector

On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 2.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.8

15m

+0.0

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.5-0.1-2.4-0.0-2.5

Next day

-5.3-0.2-5.1-0.4-4.8

-5.6+0.4-6.0-0.3-5.2

-9.0-0.4-8.6-1.0-8.0

-9.0-0.6-8.5-1.3-7.7

-10.7-0.9-9.8-1.5-9.2

-9.0-3.0-6.0-3.2-5.8

15d

-16.0-3.9-12.1-3.4-12.6

-19.0-4.8-14.2-4.0-15.0

-25.6-7.8-17.8-6.6-18.9

-18.3-7.2-11.0-8.5-9.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2 and H1 FY26 results (ended Sep 30, 2025). Standalone PAT at Rs 30.83 cr vs Rs 30 cr; consolidated PAT jumped about 146 percent in Q2 to Rs 44.07 cr and about 184 percent in H1 to Rs 90.95 cr. Standalone net sales grew about 58 percent YoY in Q2. 1:1 bonus shares allotted on Oct 7. Merger of wholly owned INM Technologies got NCLT nod in June. Sold 31 percent in Sravathi Advance Process Technologies for Rs 49.60 cr. Auditors gave unmodified limited review.

Likely market impact

Strong consolidated profit growth on better product sales, bonus issue executed, and JV stake sale adds cash. Positive for shareholders.